KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD
- PMID: 37126811
- DOI: 10.7326/J23-0023
KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD
Erratum in
-
Corrections to ACP Journal Club: Errors in Clinical Impact Ratings.Ann Intern Med. 2023 Dec;176(12):JC144. doi: 10.7326/J23-0087. Epub 2023 Oct 3. Ann Intern Med. 2023. PMID: 37782926 No abstract available.
Abstract
Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update. Ann Intern Med. 2023;176:381-387. 36623286.
Conflict of interest statement
Comment on
-
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.Ann Intern Med. 2023 Mar;176(3):381-387. doi: 10.7326/M22-2904. Epub 2023 Jan 10. Ann Intern Med. 2023. PMID: 36623286
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical